Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of vaccines for Candida albicans: fighting a skilled transformer.

Nature reviews. Microbiology - 1 Dec 2013

Cassone Antonio

Abstract excerpt

Two univalent subunit vaccines that are based on major virulence traits of Candida albicans have completed Phase I clinical trials in recent years. Although it is hoped that at least one will become the first antifungal vaccine approved for human use, there are some major obstacles to achieving this. The difficulties mostly arise from the remarkable ability of C. albicans to deceive the host immune system. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candida albicans
Share to Clinical Trials as Topic
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Immune Evasion

Share to Vaccines, Subunit

Source

Identifiers

PMID: 24232568
DOI: 10.1038/nrmicro3156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of vaccines for Candida albicans: fighting a skilled transformer.PMID 24232568Read ↗

In silico Design of a Multivalent Vaccine Against Candida albicansSemantic proximity Read ↗

Next-generation Candida albicans recombinant Als3p and Hyr1p dual antigen vaccine for invasive Candida infectionsSemantic proximity Read ↗

Design of a multi-epitope vaccine against the pathogenic fungi Candida tropicalis using an in silico approachSemantic proximity Read ↗

A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections.Semantic proximity Read ↗

The NDV-3A vaccine protects mice from multidrug resistant <i>Candida auris</i> infectionSemantic proximity Read ↗

Immunological correlates of protection mediated by a whole organism <i>Cryptococcus neoformans</i> vaccine deficient in chitosanSemantic proximity Read ↗

Monoclonal antibodies targeting surface exposed epitopes of <i>Candida albicans</i> cell wall proteins confer <i>in vivo</i> protection in an infection modelSemantic proximity Read ↗

Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal InfectionSemantic proximity Read ↗

Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine.Semantic proximity Read ↗

Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureusSemantic proximity Read ↗

An Outline of the Role of Anti-Candida Antibodies Within the Context of Passive Immunization and Protection from CandidiasisSemantic proximity Read ↗

Epitope-Based Peptide Vaccine Design Against Fructose Bisphosphate Aldolase of Candida Glabrata: An Immunomics ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.